• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Covidien sued for patent infringement of valve disinfection systems

Covidien sued for patent infringement of valve disinfection systems

September 18, 2013 By Arezu Sarvestani

Covidien sued for patent infringement of valve disinfection systems

Medical device giant Covidien (NYSE:COV) is at the center of a new infringement lawsuit accusing the company of violating a trio of Ivera Medical patents for technologies used to clean and disinfect certain valves and IV connectors.

The devices in question are small caps that fit over the ends of needle-less IV connectors, helping protect them from bacteria or other infectious agents and thus limiting patients’ exposure to blood-borne disease. Inside the caps are small sponges containing 70% isopropyl alcohol.

Ivera has been active in the court, bringing infringement lawsuits against at least 3 rivals in the last year. One lawsuit led to the validation of 3 of Ivera’s patents covering the caps, but all 3 are still under litigation.

"It seems incredible that a company like Covidien would knowingly enter a market, still in its early growth stage, with a product that is the subject of an existing patent infringement action," Ivera CEO Bob Rogers said in prepared remarks. "The exposure they have, including treble damages and the potential to disgorge all profits, for them is quite large."

Ivera has asked the court to award damages for Covidien’s alleged infringement, ban Covidien from selling the caps and to issue an injunction preventing Covidien from infringing on the patents in question. Ivera has also asked that the case be heard before a jury, legal documents show.

"Ivera has been damaged and has suffered irreparable injury due to acts of infringement by Covidien and will continue to suffer irreparable injury unless Covidien’s activities are enjoined," according to the legal complaint.

Ivera has brought similar claims against Excelsior Medical Corp., Hospira and Catheter Connections, according to Law360.com.

Filed Under: Catheters, Legal News, News Well, Patent Infringement Tagged With: Covidien, Ivera Medical

More recent news

  • A new way to monitor glucose: Glucotrack explains 3-year CBGM implant technology
  • Dexcom continues advances in AI for CGM, type 2 diabetes awareness
  • Tandem continues to deliver more options, benefits for those with diabetes
  • Breaking: Sequel to launch twiist automated insulin delivery system next month
  • Dexcom shares U.S. report on CGM benefits for type 2 diabetes

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy